NCT02952716

Treatment of Human Cord Blood Mononuclear Cell for Delayed Encephalopathy After Carbon Monoxide Poisoning

• Status: Unknown
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Liaocheng People's Hospital · Academic / Other
• Sex: All
• Age: 35 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The effects and safety of Human cord blood mononuclear cell for delayed encephalopathy after carbon monoxide poisoning

Detailed description

To evaluate the effect and mechanism of human cord blood mononuclear cell transplantation for delayed encephalopathy after carbon monoxide poisoning

Conditions

• Delayed Encephalopathy After Carbon Monoxide Poisoning

Interventions

Type	Name	Description
BIOLOGICAL	Human cord blood mononuclear cell	The patients were treated by human cord blood mononuclear cell through subarachnoid space
OTHER	hyperbaric oxygen	The patients were treated by hyperbaric oxygen

Timeline

• Start date: 2016-10-01
• Primary completion: 2018-10-01
• Completion: 2019-12-01
• First posted: 2016-11-02
• Last updated: 2017-04-18

Locations

1 site across 1 country: China